Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory model.
- 1 February 2003
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 30 (1) , 3-22
- https://doi.org/10.1023/a:1023293325245
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Analysis of Tissue-Type Plasminogen Activator Receptor (t-PAR) in Human Endothelial CellsSeminars in Thrombosis and Hemostasis, 1998
- Tissue Plasminogen Activator Binding to the Annexin II Tail DomainJournal of Biological Chemistry, 1998
- Estimating impossible curves using NONMEMBritish Journal of Clinical Pharmacology, 1996
- Isolation and Characterization of Tissue-Type Plasminogen Activator–Binding Proteoglycans From Human Umbilical Vein Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.Journal of Clinical Investigation, 1993
- Effects of Single‐Dose and Short‐Term Oral Nifedipine on Indocyanine Green Clearance as Assessed by Spectrophotometry and High Performance Liquid ChromatographyThe Journal of Clinical Pharmacology, 1990
- The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.The Journal of cell biology, 1990
- Prediction of the normal blood volume. Relation of blood volume to body habitus.Circulation, 1977
- Determination of blood volume using indocyanine green (Cardio-Green®) dyeLife Sciences, 1968
- INDOCYANINE GREEN: OBSERVATIONS ON ITS PHYSICAL PROPERTIES, PLASMA DECAY, AND HEPATIC EXTRACTION*Journal of Clinical Investigation, 1960